Effects of alanyl-glutamine dipeptide on the expression of colon-inflammatory mediators during the recovery phase of colitis induced by dextran sulfate sodium

European Journal of Nutrition

Volumn 52, Issue 3, 2013, Pages 1089-1098

  Hou, Yu Chen ^a   Chu, Chia Chou ^a   Ko, Tsui Ling ^a   Yeh, Chiu Li ^b   Yeh, Sung Ling ^a  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b CHINESE CULTURE UNIVERSITY   (Taiwan)

Author keywords

Colitis; Glutamine; Inflammation; Mucosal repair; NF B; TLR4

Indexed keywords

ALANYLGLUTAMINE DIPEPTIDE; DEXTRAN SULFATE; DIPEPTIDE; HAPTOGLOBIN; HEAT SHOCK PROTEIN 72; INTERLEUKIN 17; INTERLEUKIN 17 ALPHA; KERATINOCYTE DERIVED CHEMOKINE; MESSENGER RNA; MUCIN 2; NUCLEAR FACTOR; REGULATOR PROTEIN; TOLL LIKE RECEPTOR 4; TREFOIL FACTOR 3 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIRTH WEIGHT; BLOOD LEVEL; COLITIS; CONTROLLED STUDY; CYTOKINE GENE; DISEASE SEVERITY; DRUG EFFECT; DRUG RESPONSE; GENE; GENE EXPRESSION; HEAT SHOCK PROTEIN 72 GENE; HISTOPATHOLOGY; MALE; MOUSE; NONHUMAN; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SCORING SYSTEM;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; COLITIS, ULCERATIVE; COLON; CYTOKINES; DEXTRAN SULFATE; DIPEPTIDES; DISEASE MODELS, ANIMAL; DOWN-REGULATION; GASTROINTESTINAL AGENTS; HAPTOGLOBINS; INFLAMMATION MEDIATORS; INJECTIONS, INTRAPERITONEAL; INTESTINAL MUCOSA; MALE; MICE; MICE, INBRED C57BL; NF-KAPPA B; RANDOM ALLOCATION; TOLL-LIKE RECEPTOR 4;

LOTUS; MUS;

EID: 84879549953     PISSN: 14366207     EISSN: 14366215     Source Type: Journal    
DOI: 10.1007/s00394-012-0416-3     Document Type: Article

References (45)

1. Baumgart DC, Sandborn WJ (2007) Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet 369:1641-1657
2. Brown SJ, Mayer L (2007) The immune response in inflammatory bowel disease. Am J Gastroenterol 102:2058-2069
3. Kelsall BL (2008) Innate and adaptive mechanisms to control pathological intestinal inflammation. J Pathol 214:242-259
4. Duchmann R, Kaiser I, Hermann E, Mayet W, Ewe K, Zum Buschenfelde KHM (1995) Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD). Clin Exp Immunol 102:448-455
5. Macpherson A, Khoo UY, Forgacs I, Philpott-Howard J, Bjarnason I (1996) Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria. Gut 38:365-375
6. Palsson-McDermott EM, O'Neill LA (2004) Signal transduction by the lipopolysaccharide receptor, Toll-like receptor-4. Immunology 113:153-162
7. Hausmann M, Kiessling S, Mestermann S, Webb G, Spottl T, Andus T et al (2002) Toll-like receptors 2 and 4 are up-regulated during intestinal inflammation. Gastroenterology 122:1987-2000
8. Szebeni B, Veres G, Dezsofi A, Rusai K, Vannay A, Mraz M et al (2008) Increased expression of Toll-like receptor (TLR) 2 and TLR4 in the colonic mucosa of children with inflammatory bowel disease. Clin Exp Immunol 151:34-41
9. Ohkawara T, Takeda H, Miyashita K, Nishiwaki M, Nakayama T, Taniguchi M et al (2006) Regulation of Toll-like receptor 4 expression in mouse colon by macrophage migration inhibitory factor. Histochem Cell Biol 125:575-582
10. Ortega-Cava CF, Ishihara S, Rumi MA, Kawashima K, Ishimura N, Kazumori H et al (2003) Strategic compartmentalization of Toll-like receptor 4 in the mouse gut. J Immunol 170:3977-3985
11. Dieleman LA, Palmen MJ, Akol H, Bloemena E, Pena AS, Meuwissen SG et al (1998) Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines. Clin Exp Immunol 114:385-391
12. Shintani N, Nakajima T, Okamoto T, Kondo T, Nakamura N, Mayumi T (1998) Involvement of CD4 + T cells in the development of dextran sulfate sodium-induced experimental colitis and suppressive effect of IgG on their action. Gen Pharmacol 31:477-481
13. Egger B, Bajaj-Elliott M, MacDonald TT, Inglin R, Eysselein VE, Buchler MW (2000) Characterisation of acute murine dextran sodium sulphate colitis: cytokine profile and dose dependency. Digestion 62:240-248
14. Ito R, Kita M, Shin-Ya M, Kishida T, Urano A, Takada R et al (2008) Involvement of IL-17A in the pathogenesis of DSS-induced colitis in mice. Biochem Biophys Res Commun 377:12-16
15. Ito R, Shin-Ya M, Kishida T, Urano A, Takada R, Sakagami J et al (2006) Interferon-gamma is causatively involved in experimental inflammatory bowel disease in mice. Clin Exp Immunol 146:330-338
16. Melgar S, Karlsson A, Michaelsson E (2005) Acute colitis induced by dextran sulfate sodium progresses to chronicity in C57BL/6 but not in BALB/c mice: correlation between symptoms and inflammation. Am J Physiol Gastrointest Liver Physiol 288:G1328-G1338
17. Wang WW, Qiao SY, Li DF (2009) Amino acids and gut function. Amino Acids 37:105-110
18. Wischmeyer PE, Kahana M, Wolfson R, Ren H, Musch MM, Chang EB (2001) Glutamine reduces cytokine release, organ damage, and mortality in a rat model of endotoxemia. Shock 16:398-402
19. White JS, Hoper M, Parks RW, Clements WD, Diamond T (2005) Glutamine improves intestinal barrier function in experimental biliary obstruction. Eur Surg Res 37:342-347
20. Hering NA, Schulzke JD (2009) Therapeutic options to modulate barrier defects in inflammatory bowel disease. Dig Dis 27:450-454
21. Rao RK, Samak G (2012) Role of glutamine in protection of intestinal epithelial tight junctions. J Epithelial Biol Pharmacol 5:47-54
22. Belmonte L, Coëffier M, Le Pessot F, Miralles-Barrachina O, Hiron M, Leplingard A et al (2007) Effects of glutamine supplementation on gut barrier, glutathione content and acute phase response in malnourished rats during inflammatory shock. World J Gastroenterol 13:2833-2840
23. Mok E, Constantin B, Favreau F, Neveux N, Magaud C, Delwail A et al (2008) Hankard R. l-Glutamine administration reduces oxidized glutathione and MAP kinase signaling in dystrophic muscle of mdx mice. Pediatr Res 63:268-273
24. Iba Y, Sugimoto Y, Kamei C, Masukawa T (2003) Possible role of mucosal mast cells in the recovery process of colitis induced by dextran sulfate sodium in rats. Int Immunopharmacol 3:485-491
25. Hulsewé KW, van der Hulst RW, van Acker BA, von Meyenfeldt MF, Soeters PB (2004) Inflammation rather than nutritional depletion determines glutamine concentrations and intestinal permeability. Clin Nutr 23:1209-1216
26. Shiomi Y, Nishiumi S, Ooi M, Hatano N, Shinohara M, Yoshie T et al (2011) GCMS-based metabolomic study in mice with colitis induced by dextran sulfate sodium. Inflamm Bowel Dis 17:2261-2274
27. Israeli E, Berenshtein E, Wengrower D, Aptekar L, Kohen R, Zajicek G et al (2004) Prophylactic administration of topical glutamine enhances the capability of the rat colon to resist inflammatory damage. Dig Dis Sci 49:1705-1712
28. Vicario M, Amat C, Rivero M, Moreto M, Pelegri C (2007) Dietary glutamine affects mucosal functions in rats with mild DSS-induced colitis. J Nutr 137:1931-1937
29. Xue H, Sufit AJ, Wischmeyer PE (2011) Glutamine therapy improves outcome of in vitro and in vivo experimental colitis models. JPEN J Parenter Enteral Nutr 35:188-197
30. Wang F, Zhao HY, Zhang ST, Gong YZ, Zhang HF, Zhang C (2011) Effect of enteral nutrition on dextran sulfate sodium-induced colitis in rats. J Dig Dis 12:453-458
31. Kretzmann NA, Fillmann H, Mauriz JL, Marroni CA, Marroni N, Gonzalez-Gallego J et al (2008) Effects of glutamine on proinflammatory gene expression and activation of nuclear factor kappa B and signal transducers and activators of transcription in TNBS-induced colitis. Inflamm Bowel Dis 14:1504-1513
32. Fukata M, Chen A, Klepper A, Krishnareddy S, Vamadevan AS, Thomas LS et al (2006) Cox-2 is regulated by Toll-like receptor-4 (TLR4) signaling: role in proliferation and apoptosis in the intestine. Gastroenterology 131:862-877
33. Ungaro R, Fukata M, Hsu D, Hernandez Y, Breglio K, Chen A et al (2009) A novel Toll-like receptor 4 antagonist antibody ameliorates inflammation but impairs mucosal healing in murine colitis. Am J Physiol Gastrointest Liver Physiol 296:G1167-G1179
34. Simeonidis S, Stauber D, Chen G, Hendrickson WA, Thanos D (1999) Mechanisms by which IκB proteins control NF-κB activity. Proc Natl Acad Sci USA 96:49-54
35. Magne N, Toillon RA, Bottero V, Didelot C, Houtte PV, Gerard JP et al (2006) NF-kappaB modulation and ionizing radiation: mechanisms and future directions for cancer treatment. Cancer Lett 231:158-168
36. Khoshnan A, Tindell C, Laux I, Bae D, Bennett B, Nel AE (2000) The NF-kappa B cascade is important in Bcl-xL expression and for the anti-apoptotic effects of the CD28 receptor in primary human CD4 + lymphocytes. J Immunol 165:1743-1754
37. Kolls JK, Linden A (2004) Interleukin-17 family members and inflammation. Immunity 21:467-476
38. Strieter RM, Kunkel SL, Keane MP, Standiford TJ (1999) Chemokines in lung injury: Thomas A. Neff lecture. Chest 116:103S-110S
39. Chu CC, Hou YC, Pai MH, Chao CJ, Yeh SL (2011) Pretreatment with alanyl-glutamine suppresses T-helper-cell-associated cytokine expression and reduces inflammatory responses in mice with acute DSS-induced colitis. J Nutr Biochem [Epub ahead of print]
40. Garrido C, Schmitt E, Cande C, Vahsen N, Parcellier A, Kroemer G (2003) HSP27 and HSP70: potentially oncogenic apoptosis inhibitors. Cell Cycle 2:579-584
41. Lanneau D, Brunet M, Frisan E, Solary E, Fontenay M, Garrido C (2008) Heat shock proteins: essential proteins for apoptosis regulation. J Cell Mol Med 12:743-761
42. Sreedhar AS, Csermely P (2004) Heat shock proteins in the regulation of apoptosis: new strategies in tumor therapy: a comprehensive review. Pharmacol Ther 101:227-257
43. Wischmeyer PE, Musch MW, Madonna MB, Thisted R, Chang EB (1997) Glutamine protects intestinal epithelial cells: role of inducible HSP70. Am J Physiol 272:G879-G884
44. Shirazi T, Longman RJ, Corfield AP, Probert CS (2000) Mucins and inflammatory bowel disease. Postgrad Med J 76:473-478
45. Kindon H, Pothoulakis C, Thim L, Lynch-Devaney K, Podolsky DK (1995) Trefoil peptide protection of intestinal epithelial barrier function: cooperative interaction with mucin glycoprotein. Gastroenterology 109:516-523